ORBIMED ADVISORS LLC 13D and 13G filings for RAPT Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-11-14 6:18 pm Sale | 2025-09-30 | 13G | RAPT Therapeutics, Inc. RAPT | ORBIMED ADVISORS LLC | 1,086,618 6.600% | -555,290 (-33.82%) | Filing |
| 2025-02-14 4:32 pm Purchase | 2024-12-31 | 13G | RAPT Therapeutics, Inc. RAPT | ORBIMED ADVISORS LLC | 1,641,908 9.900% | 1,641,908 (New Position) | Filing |